Thailand Furthers Cost-Cutting Measures, Putting Additional Pressure On MNCs
This article was originally published in PharmAsia News
Executive Summary
The Thai government plans to institute more cost-cutting measures on drugs and services in the country – a plan that will put a tighter squeeze on MNCs operating in Thailand.
You may also be interested in...
Thailand's Cost Control Measures And What They Mean For Pharma - IMS Analysis
SHANGHAI - Thailand's recent clampdown on public healthcare spending means multinational drug makers will have to look for news ways to tap the country's drug market, according to IMS Health
Sanofi Asks Thailand To Review Compulsory Licensing Policy
Sanofi-Aventis sent a request to the previous Thai Minister of Commerce Mingkwan Sangsuwan to review the process of compulsory licensing on patented drugs, Graham Almond, Sanofi-Aventis Thailand general manager told PharmAsia News.
Thai Officials Say Compulsory Licenses Will Not Deter Biotech Business – BIO 2008 Exclusive
SAN DIEGO - Industry furor over Thailand's compulsory license position will not deter multinational companies from investing in the country, according to Thai officials who sat down with PharmAsia News during the BIO 2008 convention in San Diego